| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |